Bright and brilliant: future funding for Victorian science
31 October, 2002 by Melissa Trudinger'Victorians: Bright Ideas, Brilliant Future' -- a new innovation statement from the Victorian government announcing $310 million in new funding for science, technology and research initiatives -- was today launched by State Premier Steve Bracks and Innovation Minister John Brumby.
Don't fall behind in bio-IT, observers warn
29 October, 2002 by Iain ScottA Sydney briefing last week on the global bioinformatics market was told that Australia must boost its record on science spending or risk falling behind the so-called 'Asian tiger' economies of its neighbours.
'Poetic justice' earns licence deal for Genetic Technologies
28 October, 2002 by Melissa TrudingerIn a newspaper opinion piece in March 2001, Genetic Technologies' executive chairman Dr Mervyn Jacobson defended the rights of US genetic testing company Myriad Genetics to charge high prices for its patented gene testing service for familial breast cancer.
Bioclusters feature: Get it together
23 October, 2002 by Pete YoungBioclusters are complex animals whose care and feeding now commands respectful attention in the upper echelons of Australia's biotechnology community.
AusBiotech launches bioinformatics group
21 October, 2002 by Iain ScottIndustry association AusBiotech has today launched a special interest group to drive collaboration between the IT, biotechnology and medical device sectors.
Gene therapy used in cystic fibrosis treatment
21 October, 2002 by Melissa TrudingerAdelaide researchers have made progress on the development of a new gene therapy technique for cystic fibrosis, utilising a naturally occurring detergent in combination with a retroviral delivery vector.
Protein discovery aids neurone research
14 October, 2002 by Melissa TrudingerAustralian researchers have unravelled part of the process controlling the production of new neurones from stem cells in the brain.
Mouse models feature: How to make a mutant mouse
11 October, 2002 by Graeme O'NeillThere are two basic types of rodent model for investigating inherited genetic disorders or health problems in humans -- the 'knockout' and the 'knock-in' mouse.
Mouse models feature: It's a knockout
11 October, 2002 by Graeme O'NeillMaking mutant mice was once a challenge, but in the Speedy Gonzales business of biotech and medical research, it's now routine, and a time-consuming distraction from the real game of investigating gene function.
Asia gets serious about bio-IT
09 October, 2002 by David BinningGreat strides made in the areas of genomics, proteomics and other key features across the developing biotech landscape have dramatically altered the playing field for bioinformatics groups Asia is now expected to realize a massive surge in demand for IT systems as the region races to catch up with the rest of the world.
New-look Autogen touts Merck deal
08 October, 2002 by Melissa TrudingerActing chairman Brett Heading introduced a "new" Autogen to friends and supporters of the company today at the launch of its new high-throughput genotyping facility at the Toorak campus of Deakin University in Melbourne.
BioMelbourne Network to become independent agency
08 October, 2002 by Melissa TrudingerThe BioMelbourne Network has received a boost from the Victorian government in the form of $750,000 funding over the next three years to launch the organisation as an independent state-based biotechnology agency.
CSIRO bets on Beowulf cluster
04 October, 2002 by David BraueLife science researchers at CSIRO will soon get access to a powerful new computing cluster as the nation's largest scientific organisation prepares for the February launch of a dedicated bioinformatics supercomputer.
Big bucks for infrastructure in latest ARC round
04 October, 2002 by Iain ScottLife science related infrastructure projects have been funded to the tune of nearly $10.5 million in the latest round of Australian Research Council linkage, infrastructure and equipment (LIEF) grants.
Cytopia's Linux investment speeds molecular candidate modelling
30 September, 2002 by David BraueA month after its installation, a major computerised modelling system, based on the Linux operating system, is delivering substantial cost and time savings for biotech venture Cytopia.
